Novel Shoe Device NUSHU to Measure Gait Analysis in Parkinson's Patients
Recruiting now · Not applicable
Conditions studied: Parkinson's Disease (PD)
In brief
Gait changes in Parkinson's disease are complex, variable, and difficult to detect during short clinic assessments. The aim of this study is to collect gait measurements in Parkinson's patients through sensors in a novel shoe device, NUSHU by Magnes AG. The shoe additionally provides vibrational feedback that can potentially help gait difficulties experienced by Parkinson's patients.
Key facts
- Study ID
- NCT06975059
- Run by
- Weill Medical College of Cornell University
- People needed
- 40
- Starts
- 2025-05-30
- Expected to finish
- 2030-07-01
- Last updated by the study team
- 2025-10-01
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Male or female ≥ 18 years of age.
- A diagnosis of Parkinson's disease
- Able to give written informed consent (as determined by the investigator)
- Can converse in English and read and perform all study activities
- Has willingness and ability to comply with study requirements
You may not qualify if…
- Diagnosis of an atypical parkinsonism syndrome, drug-induced parkinsonism, essential tremor, or other diagnoses that explain movement symptoms other than PD
- A diagnosis of significant CNS disease other than PD such as stroke, multiple sclerosis, epilepsy
- Persons with disorders other than PD significantly affecting gait as determined by the investigator
- History of MRI brain scan indicative of clinically significant abnormality as determined by the investigator
- Inability to wear interventional device
- Unable to ambulate independently at least with assistive walking device but without additional person assistance
- Pregnant or planning pregnancy within study timeframe
- Montreal Cognitive Assessment (MoCA) score < 22 at screening
- Resides in a nursing home or assisted care facility
- Healthy Controls:
- Inclusion Criteria:
- Male or female ≥ 18 years of age.
- No neurological disease or other significant gait impairment as deemed by the study investigator
Where it is running
- Weill Cornell — New York, New York, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.